Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery
- PMID: 22780955
- DOI: 10.1016/j.addr.2012.07.001
Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery
Abstract
Advances in biomedical research have generated an unprecedented number of potential targets for therapeutic intervention to treat disease or delay disease progression. Unfortunately, many of these targets are not druggable as they are intracellular, present in many cell types, poorly soluble or rapidly inactivated. Although synthetic drug vehicles have successfully circumvented many of these problems, natural particulates such as exosomes that intrinsically possess many attributes of a drug delivery vehicle are highly attractive as potentially better alternatives. Of the cell types known to produce exosomes, the readily available proliferative, immunosuppressive and clinically tested human mesenchymal stem cell (MSC) is the most prolific producer. Its exosomes are therapeutic in animal model of disease and exhibit immunosuppressive activity. The quality and quantity of exosome production is not compromised by immortalization to create a permanent MSC cell line. Therefore, MSC is well suited for mass production of exosomes that are ideal for drug delivery.
Copyright © 2012 Elsevier B.V. All rights reserved.
Similar articles
-
Exosomes for drug delivery - a novel application for the mesenchymal stem cell.Biotechnol Adv. 2013 Sep-Oct;31(5):543-51. doi: 10.1016/j.biotechadv.2012.08.008. Epub 2012 Aug 25. Biotechnol Adv. 2013. PMID: 22959595 Review.
-
Mesenchymal stem cell exosome ameliorates reperfusion injury through proteomic complementation.Regen Med. 2013 Mar;8(2):197-209. doi: 10.2217/rme.13.4. Regen Med. 2013. PMID: 23477399 Review.
-
Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.J Control Release. 2014 Oct 28;192:262-70. doi: 10.1016/j.jconrel.2014.07.042. Epub 2014 Jul 30. J Control Release. 2014. PMID: 25084218
-
Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease.Regen Med. 2011 Jul;6(4):481-92. doi: 10.2217/rme.11.35. Regen Med. 2011. PMID: 21749206 Review.
-
Mesenchymal-stem-cell-derived exosomes accelerate skeletal muscle regeneration.FEBS Lett. 2015 May 8;589(11):1257-65. doi: 10.1016/j.febslet.2015.03.031. Epub 2015 Apr 8. FEBS Lett. 2015. PMID: 25862500
Cited by
-
Mesenchymal Stem Cell-Derived Extracellular Vesicles and Their Therapeutic Potential.Stem Cells Int. 2020 Aug 24;2020:8825771. doi: 10.1155/2020/8825771. eCollection 2020. Stem Cells Int. 2020. PMID: 32908543 Free PMC article. Review.
-
The Micro-RNA Cargo of Extracellular Vesicles Released by Human Adipose Tissue-Derived Mesenchymal Stem Cells Is Modified by Obesity.Front Cell Dev Biol. 2021 May 20;9:660851. doi: 10.3389/fcell.2021.660851. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34095124 Free PMC article.
-
Advancements in Engineering Planar Model Cell Membranes: Current Techniques, Applications, and Future Perspectives.Nanomaterials (Basel). 2024 Sep 13;14(18):1489. doi: 10.3390/nano14181489. Nanomaterials (Basel). 2024. PMID: 39330645 Free PMC article. Review.
-
Extracellular Vesicles and Their Current Role in Cancer Immunotherapy.Cancers (Basel). 2021 May 10;13(9):2280. doi: 10.3390/cancers13092280. Cancers (Basel). 2021. PMID: 34068657 Free PMC article. Review.
-
Possible Combinatorial Utilization of Phytochemicals and Extracellular Vesicles for Wound Healing and Regeneration.Int J Mol Sci. 2024 Sep 26;25(19):10353. doi: 10.3390/ijms251910353. Int J Mol Sci. 2024. PMID: 39408681 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources